Complement activation during liver transplantation. 1993

H Tomasdottir, and B A Henriksson, and J P Bengtson, and A Bengtsson, and O Stenqvist, and H Persson
Department of Anaesthesiology and Intensive Care, Sahlgren Hospital, Göteborg, Sweden.

Twelve patients with end-stage liver disease undergoing liver transplantation were studied regarding complement activation and formation of anaphylatoxins (C3a and C5a) and terminal C5b-9 complement complexes (TCC) after reperfusion of the grafted liver. Blood samples for complement variables (C1INH, C3, C4, C5, C3a, C5a, and TCC) were drawn preoperatively, before the anhepatic phase, 1 min before, and 2, 15, and 60 min after the start of reperfusion of the grafted liver. Activation of complement was observed during the operation. The C1INH, C3, C4, and C5 plasma concentrations decreased during the entire operation while the anaphylatoxin C3a and the terminal C5b-9 complement complex increased after the reperfusion of the grafted liver. Activation of complement with the formation of biologically active substances like anaphylatoxins and terminal C5b-9 complement complexes may be one explanation for circulatory complications often seen in patients undergoing orthotopic liver transplantation.

UI MeSH Term Description Entries
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations
D003169 Complement Inactivator Proteins Serum proteins that negatively regulate the cascade process of COMPLEMENT ACTIVATION. Uncontrolled complement activation and resulting cell lysis is potentially dangerous for the host. The complement system is tightly regulated by inactivators that accelerate the decay of intermediates and certain cell surface receptors. Complement Cytolysis Inhibiting Proteins,Complement Cytolysis Inhibitor Proteins,Complement Inactivating Proteins,Serum Complement Inactivators,Complement Inactivators, Serum,Inactivating Proteins, Complement,Inactivator Proteins, Complement,Inactivators, Serum Complement,Proteins, Complement Inactivating,Proteins, Complement Inactivator
D003181 Complement C4 A glycoprotein that is important in the activation of CLASSICAL COMPLEMENT PATHWAY. C4 is cleaved by the activated COMPLEMENT C1S into COMPLEMENT C4A and COMPLEMENT C4B. C4 Complement,C4 Complement Component,Complement 4,Complement C4, Precursor,Complement Component 4,Pro-C4,Pro-complement 4,C4, Complement,Complement Component, C4,Complement, C4,Component 4, Complement,Component, C4 Complement,Pro C4,Pro complement 4
D003182 Complement C5 C5 plays a central role in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C5 is cleaved by C5 CONVERTASE into COMPLEMENT C5A and COMPLEMENT C5B. The smaller fragment C5a is an ANAPHYLATOXIN and mediator of inflammatory process. The major fragment C5b binds to the membrane initiating the spontaneous assembly of the late complement components, C5-C9, into the MEMBRANE ATTACK COMPLEX. C5 Complement,Complement 5,Complement C5, Precursor,Complement Component 5,Precursor C5,Pro-C5,Pro-complement 5,C5, Complement,C5, Precursor,C5, Precursor Complement,Complement, C5,Component 5, Complement,Precursor Complement C5,Pro C5,Pro complement 5
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H Tomasdottir, and B A Henriksson, and J P Bengtson, and A Bengtsson, and O Stenqvist, and H Persson
August 2000, Acta anaesthesiologica Scandinavica,
H Tomasdottir, and B A Henriksson, and J P Bengtson, and A Bengtsson, and O Stenqvist, and H Persson
June 1994, Transplantation,
H Tomasdottir, and B A Henriksson, and J P Bengtson, and A Bengtsson, and O Stenqvist, and H Persson
May 1997, Transplantation proceedings,
H Tomasdottir, and B A Henriksson, and J P Bengtson, and A Bengtsson, and O Stenqvist, and H Persson
September 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
H Tomasdottir, and B A Henriksson, and J P Bengtson, and A Bengtsson, and O Stenqvist, and H Persson
October 1989, Journal of biomaterials applications,
H Tomasdottir, and B A Henriksson, and J P Bengtson, and A Bengtsson, and O Stenqvist, and H Persson
January 1988, Annales francaises d'anesthesie et de reanimation,
H Tomasdottir, and B A Henriksson, and J P Bengtson, and A Bengtsson, and O Stenqvist, and H Persson
February 1985, The New England journal of medicine,
H Tomasdottir, and B A Henriksson, and J P Bengtson, and A Bengtsson, and O Stenqvist, and H Persson
January 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
H Tomasdottir, and B A Henriksson, and J P Bengtson, and A Bengtsson, and O Stenqvist, and H Persson
April 2000, Transplantation,
H Tomasdottir, and B A Henriksson, and J P Bengtson, and A Bengtsson, and O Stenqvist, and H Persson
March 1982, Clinical and experimental immunology,
Copied contents to your clipboard!